Related Experiment Video
Updated: Jul 8, 2026
09:26
Disruption of Frontal Lobe Neural Synchrony During Cognitive Control by Alcohol Intoxication
Published on: February 6, 2019
Alcohol consumption, mild cognitive impairment, and progression to dementia
V Solfrizzi1, A D'Introno, A M Colacicco
1Department of Geriatrics, Center for Aging Brain, Memory Unit, University of Bari, Policlinico, Bari, Italy. v.solfrizzi@geriatria.uniba.it
Neurology
|May 23, 2007
Summary
Moderate alcohol consumption, defined as less than one drink daily, may slow the progression of mild cognitive impairment to dementia. This finding suggests a potential protective effect of light drinking in older adults.
Area of Science:
- Neuroscience
- Gerontology
- Epidemiology
Background:
- Mild cognitive impairment (MCI) is a risk factor for dementia.
- Understanding modifiable factors influencing MCI progression is crucial for public health.
Purpose of the Study:
- To investigate the association between alcohol consumption and the incidence of MCI.
- To determine the impact of alcohol intake on the progression of MCI to dementia.
Main Methods:
- Longitudinal study of 1,445 non-cognitively impaired and 121 MCI individuals (aged 65-84).
- Alcohol consumption assessed at baseline; follow-up of 3.5 years.
- Classification of MCI and dementia using established clinical criteria.
Main Results:
- No significant association found between alcohol consumption and MCI incidence.
- Moderate alcohol intake ( < 1 drink/day, especially wine) was associated with a reduced rate of MCI progression to dementia compared to abstainers.
- Higher alcohol consumption (>= 1 drink/day) did not show a significant association with MCI progression.
Conclusions:
- Moderate alcohol consumption, particularly wine, may be neuroprotective against dementia progression in individuals with MCI.
- Further research is warranted to elucidate the mechanisms and confirm these findings.
Related Concept Videos
01:27CNS Depressants: Alcohol and Nicotine
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...